The value of narrowband imaging with magnifying endoscopy in the surveillance of patients with intestinal metaplasia and dysplasia of the gastric mucosa

The value of narrowband imaging with magnifying endoscopy in the surveillance of patients with intestinal metaplasia and dysplasia of the gastric mucosa - NIMGAS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30828

Enrollment

130

Registered

2007-10-02

Start date

2007-11-09

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premalignant gastric lesions

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients undergoing a surveillance endoscopy because of a previous diagnosis of intestinal metaplasia or dysplasia of the gastric mucosa Patients with gastric intestinal metaplasia or dysplasie diagnosed after the start of the study

Exclusion criteria

Exclusion criteria: Coagulopathy uncorrected at the time of endoscopy or thrombocytopenia

Design outcomes

Primary

Measure	Time frame
The number of detected lesions with histological proven intestinal metaplasia or dysplasia after NBI-ME as compared to the number of detected lesion with histological proven intestinal metaplasia or dysplasia after conventional endoscopy.	—

Secondary

Measure	Time frame
Correspondence between serologic markers (pepsinogen I, II and gastrin 17) and H. pylori data and histology	—

Countries

Netherlands

Outcome results